|
Right Treatment, Right Patient: Evidence-Based Approaches to the Treatment of Moderate-to-Severe Atopic Dermatitis Snippet 1: Currently Available Injectable Biologic Therapies for Moderate-to-Severe Atopic Dermatitis (AD)
Target Audience
This activity is designed to meet the educational needs of dermatology and allergy physicians, nurse practitioners, PAs, and nurses who care for patients with moderate-to-severe atopic dermatitis.
Program Overview
This activity features a case presentation, a brief overview of currently available injectable biologic therapies, and insights from an expert faculty.
Learning Objectives
After completing this activity, the participant should be better able to::
Identify ... |
|
Right Treatment, Right Patient: Evidence-Based Approaches to the Treatment of Moderate-to-Severe Atopic Dermatitis Snippet 2: Currently Available Oral Therapies for Moderate-to-Severe Atopic Dermatiti
Target Audience
This activity is designed to meet the educational needs of dermatology and allergy physicians, nurse practitioners, PAs, and nurses who care for patients with moderate-to-severe atopic dermatitis.
Program Overview
This activity features a case presentation, a brief overview of currently available oral therapies, and insights from expert faculty.
Learning Objectives
After completing this activity, the participant should be better able to::
Identify the biologic prope... |
|
Dermatological Compounding
September 13th- 14th, 2024
DERMATOLOGICAL COMPOUNDING is an accredited 15 hour (1.5 CEUs) knowledge / application-based course that comprises a blend of didactic lectures for theoretical understanding and laboratory activities for practical application. This approach enhances an already established skill of compounding, providing you with a more in-depth insight into the field. However, it is recommended for participants to have a solid understanding of fundamental compounding techniques an... |
|
Seeking Control for Moderate-to-Severe Asthma: The Underestimated Impact of Comorbidities Along the Lifespan
Target Audience
The primary target audience for this activity are pulmonologists, allergists/immunologists, and specialty advanced practice providers (NPs and PAs). The secondary audience for this activity are primary care physicians, and general practice NPs and PAs.
Program Overview
Severe uncontrolled asthma leads to multiple negative health and socioeconomic effects. Asthma is also associated with comorbid conditions, some driven by shared type 2 inflammatory pathophysiology, includin... |